Advertisement
Cleveland Clinic researchers receive $2 million grant from the National Institutes of Health
Open-source artificial intelligence technology uses human genetic data to find candidate drugs
Network proximity and EHR analyses identify diabetes drug as a top candidate for risk reduction
Findings underscore need for racial diversity in ongoing and future trials
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
A case study in how pharmacogenomic testing can be helpful if not always essential
$14M NIH grant supports research toward medications to prevent progression
Retrospective study yields clues to understanding risk of secondary myeloid neoplasms
New Cleveland Clinic fellowship fosters expertise in the genetics of epilepsy
Renal genetic testing confirms diagnosis, guides management
A model predicting response to CGRP-inhibiting monoclonal antibodies is under development
Advertisement
Advertisement